Ota F, Parker D, Dwyer J M, Turk J L
Int Arch Allergy Appl Immunol. 1980;61(2):183-91. doi: 10.1159/000232432.
Heterologous antisera against guinea pig B lymphocytes have been prepared in rabbits. Sera, obtained 1 week after a third injection of cells from a guinea pig leukemic B cell line (L2C), were absorbed with guinea pig and sheep erythrocytes and guinea pig thymocytes. In the presence of complement, selected antisera killed both L2C cells (85%) and B cells from Hartley outbred guinea pigs (85%). Normal rabbit serum kills guinea pig thymocytes and this ability was enhanced in the sera obtained from rabbits immunized with L2C cells. After three absorptions with thymocytes the antisera retained their cytotoxicity for B cells but did not kill guinea pig thymocytes or peripheral T lymphocytes. The antigenic determinants on the L2C cells that simulate anti-B cell activity are unknown but surface membrane immunoglobulins were excluded. The development of methodology for obtaining a potent and specific anti-guinea pig B cell serum should significantly improve the usefulness of guinea pigs as animals for in vitro studies.
已在兔体内制备了针对豚鼠B淋巴细胞的异种抗血清。在第三次注射来自豚鼠白血病B细胞系(L2C)的细胞1周后获得血清,并用豚鼠和绵羊红细胞以及豚鼠胸腺细胞进行吸收。在补体存在的情况下,所选抗血清可杀死L2C细胞(85%)和Hartley远交豚鼠的B细胞(85%)。正常兔血清可杀死豚鼠胸腺细胞,在用L2C细胞免疫的兔所获得的血清中,这种能力增强。在用胸腺细胞进行三次吸收后,抗血清对B细胞仍保留其细胞毒性,但不杀死豚鼠胸腺细胞或外周T淋巴细胞。L2C细胞上模拟抗B细胞活性的抗原决定簇尚不清楚,但已排除表面膜免疫球蛋白。获得高效特异性抗豚鼠B细胞血清的方法学发展应能显著提高豚鼠作为体外研究动物的实用性。